Skip to content

Clinical trials

Observational Multiple Organ Failure trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Organ Failure Phase: Observational Country / region: China Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20131
20151
20171
20184
20222
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed4
Not yet recruiting2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hai Li2
Beijing Anzhen Hospital1
Children's Hospital of Fudan University1
Chinese PLA General Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
First Affiliated Hospital, Sun Yat-Sen University1
Guoping Lu1
Huashan Hospital1
Jiang Jianxin1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Organ Failure16
Sepsis8
Critical Illness4
Acute Kidney Injury2
Acute-On-Chronic Liver Failure2
Systemic Inflammatory Response Syndrome2
Wounds and Injuries2
COVID-191
Cytokine Release Syndrome1
Dysbiosis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.